Deutsche Bank
AGTC

Deutsche Bank’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Deutsche Bank’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,990
Closed -$137K – 4924
2021
Q1 		$137K Buy
26,990
+9,677
+56% +$50.2K ﹤0.01% 3818
2020
Q4 		$71K Buy
17,313
+5,440
+46% +$26.7K ﹤0.01% 4012
2020
Q3 		$58K Buy
11,873
+1,127
+10% +$6.16K ﹤0.01% 3818
2020
Q2 		$60K Buy
+10,746
New +$49.2K ﹤0.01% 3726
2020
Q1 		– Sell
-32,433
Closed -$146K – 5012
2019
Q4 		$146K Buy
32,433
+4,333
+15% +$13.7K ﹤0.01% 3396
2019
Q3 		$116K Sell
28,100
-7,494
-21% -$27.1K ﹤0.01% 3483
2019
Q2 		$134K Buy
35,594
+35,194
+8,799% +$144K ﹤0.01% 4058
2019
Q1 		$1K Sell
400
-50,873
-99% -$178K ﹤0.01% 5127
2018
Q4 		$127K Sell
51,273
-12,627
-20% -$74K ﹤0.01% 4111
2018
Q3 		$466K Sell
63,900
-26,100
-29% -$114K ﹤0.01% 3824
2018
Q2 		$333K Buy
90,000
+67,768
+305% +$314K ﹤0.01% 4049
2018
Q1 		$85K Sell
22,232
-31,791
-59% -$134K ﹤0.01% 4575
2017
Q4 		$194K Sell
54,023
-40,641
-43% -$153K ﹤0.01% 4044
2017
Q3 		$373K Sell
94,664
-88,261
-48% -$405K ﹤0.01% 3563
2017
Q2 		$932K Buy
182,925
+55,142
+43% +$310K ﹤0.01% 3080
2017
Q1 		$881K Buy
127,783
+47,599
+59% +$372K ﹤0.01% 2738
2016
Q4 		$749K Sell
80,184
-44,264
-36% -$399K ﹤0.01% 2891
2016
Q3 		$1.22M Buy
124,448
+72,933
+142% +$984K ﹤0.01% 2701
2016
Q2 		$727K Sell
51,515
-21,148
-29% -$330K ﹤0.01% 3074
2016
Q1 		$1.01M Sell
72,663
-3,065
-4% -$45K ﹤0.01% 2801
2015
Q4 		$1.54M Buy
75,728
+2,741
+4% +$42.3K ﹤0.01% 2623
2015
Q3 		$958K Buy
72,987
+50,874
+230% +$844K ﹤0.01% 2983
2015
Q2 		$339K Buy
22,113
+2,106
+11% +$40.4K ﹤0.01% 3619
2015
Q1 		$399K Sell
20,007
-1,551
-7% -$34.7K ﹤0.01% 3429
2014
Q4 		$452K Sell
21,558
-3,092
-13% -$63K ﹤0.01% 3746
2014
Q3 		$457K Buy
24,650
+4,626
+23% +$83.8K ﹤0.01% 3561
2014
Q2 		$462K Buy
+20,024
New +$353K ﹤0.01% 3524

Other funds holding AGTC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Deutsche Bank's AGTC Position: Q2 2021 in Review

Deutsche Bank sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 26,990 shares — an estimated $137K sold.

Deutsche Bank first reported a position in AGTC in Q2 2014 and held it in 27 quarters. The position peaked at $1.54M in Q4 2015. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • Deutsche Bank reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 26,990 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $137K.
  • Deutsche Bank first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 27 quarters.
  • Deutsche Bank's Applied Genetic Technologies Corporation position peaked at $1.54M in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.